Medium 5.3Published Oct 26, 2026

CVE-2026-116746QloApps 1.6.0 through 1.7.0 Unauthorized Hotel Review Submission via qlohotelreview

Updated under an hour ago (Oct 29, 2026, 10:00 PM ET)

Does this affect you?

It affects qloapps. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Do this next

Start free and add your stackFree account, 3 products Every CVE for qloapps Exploited in the last 30 days

QloApps 1.6.0 through 1.7.0 contains a missing authorization vulnerability in the qlohotelreview module's AddReview AJAX action that allows unauthenticated attackers to submit reviews for arbitrary orders. Attackers can reuse the publicly exposed review_ajax_token and enumerate sequential id_order values to post fake ratings and reviews attributed to other customers.

CVSS: 5.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:N
Weakness (CWE): CWE-639
Known exploited: Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days): Not loaded for this CVE
Assigned by: VulnCheck
NVD analysis: Deferred
Record last updated: Oct 27, 2026
First seen by InfoSec Signals: Oct 26, 2026

Affected products

Affected products

qloapps qloapps qloapps:qloapps (from the name)	from 1.6.0 through 1.7.0	CNA record

References

References

https://github.com/Qloapps/QloApps/pull/1757	issue-tracking, patch
https://github.com/Qloapps/QloApps/commit/d5ce1333c99b9619fc17412580fbb28c02be2580	patch
https://github.com/Qloapps/QloApps	product
https://github.com/Qloapps/QloApps/blob/v1.7.0/modules/qlohotelreview/controllers/front/default.php#L37-L104	technical-description
https://www.vulncheck.com/advisories/qloapps-1.6.0-through-1.7.0-unauthorized-hotel-review-submission-via-qlohotelreview	third-party-advisory

The CVE record on cve.org NVD's entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.